Literature DB >> 28813221

Inflammatory Bowel Disease and the NLRP3 Inflammasome.

Thirumala-Devi Kanneganti1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28813221     DOI: 10.1056/NEJMcibr1706536

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  22 in total

1.  Bacterial Type I CRISPR-Cas systems influence inflammasome activation in mammalian host by promoting autophagy.

Authors:  Qun Wu; Biao Wang; Chuanmin Zhou; Ping Lin; Shugang Qin; Pan Gao; Zhihan Wang; Zhenwei Xia; Min Wu
Journal:  Immunology       Date:  2019-09-17       Impact factor: 7.397

Review 2.  An update on cell intrinsic negative regulators of the NLRP3 inflammasome.

Authors:  Barun Poudel; Prajwal Gurung
Journal:  J Leukoc Biol       Date:  2018-01-26       Impact factor: 4.962

Review 3.  Differential role of the NLRP3 inflammasome in infection and tumorigenesis.

Authors:  Sarang Tartey; Thirumala-Devi Kanneganti
Journal:  Immunology       Date:  2019-02-14       Impact factor: 7.397

4.  Critical Role for the NLRP3 Inflammasome in Mediating IL-1β Production in Shigella sonnei-Infected Macrophages.

Authors:  Lan-Hui Li; Tzu-Ling Chen; Hsiao-Wen Chiu; Chung-Hua Hsu; Chien-Chun Wang; Tzu-Ting Tai; Tz-Chuen Ju; Fang-Hsin Chen; Oleg V Chernikov; Wen-Chiuan Tsai; Kuo-Feng Hua
Journal:  Front Immunol       Date:  2020-06-03       Impact factor: 7.561

5.  A Comparative Study on the Efficacy of NLRP3 Inflammasome Signaling Inhibitors in a Pre-clinical Model of Bowel Inflammation.

Authors:  Carolina Pellegrini; Matteo Fornai; Rocchina Colucci; Laura Benvenuti; Vanessa D’Antongiovanni; Gianfranco Natale; Federica Fulceri; Marta Giorgis; Elisabetta Marini; Simone Gastaldi; Massimo Bertinaria; Corrado Blandizzi; Luca Antonioli
Journal:  Front Pharmacol       Date:  2018-12-03       Impact factor: 5.810

6.  Tofacitinib restores the balance of γδTreg/γδT17 cells in rheumatoid arthritis by inhibiting the NLRP3 inflammasome.

Authors:  Xinyu Yang; Ning Zhan; Yang Jin; Hanzhi Ling; Chipeng Xiao; Zhen Xie; Hao Zhong; Xinxin Yu; Runhua Tang; Jinglan Ma; Jubo Guan; Guoyu Yin; Gan Wu; Liangjing Lu; Jianguang Wang
Journal:  Theranostics       Date:  2021-01-01       Impact factor: 11.556

Review 7.  Nutrients Mediate Intestinal Bacteria-Mucosal Immune Crosstalk.

Authors:  Ning Ma; Pingting Guo; Jie Zhang; Ting He; Sung Woo Kim; Guolong Zhang; Xi Ma
Journal:  Front Immunol       Date:  2018-01-24       Impact factor: 7.561

8.  Systems pharmacology reveals the unique mechanism features of Shenzhu Capsule for treatment of ulcerative colitis in comparison with synthetic drugs.

Authors:  Wuwen Feng; Hui Ao; Shijun Yue; Cheng Peng
Journal:  Sci Rep       Date:  2018-11-01       Impact factor: 4.379

9.  Rapamycin‑induced autophagy attenuates hormone‑imbalance‑induced chronic non‑bacterial prostatitis in rats via the inhibition of NLRP3 inflammasome‑mediated inflammation.

Authors:  Jingxiao Lu; Yang Su; Xianguo Chen; Yuan Chen; Pengcheng Luo; Fangyou Lin; Jie Zhang
Journal:  Mol Med Rep       Date:  2018-11-21       Impact factor: 2.952

10.  Colonic mucosal and serum expression of microRNAs in canine large intestinal inflammatory bowel disease.

Authors:  Alexandros Ο Konstantinidis; Dimitra Pardali; Katerina K Adamama-Moraitou; Maria Gazouli; Chrysostomos I Dovas; Evangelia Legaki; Georgia D Brellou; Ioannis Savvas; Albert E Jergens; Timoleon S Rallis; Karin Allenspach
Journal:  BMC Vet Res       Date:  2020-02-22       Impact factor: 2.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.